What are the side effects of Victoza and does Medicare cover it?

Patty Bonsignore


The main side effect of Victoza is nausea, and this usually resolves after the first few weeks. Victoza can also cause low blood glucose levels when used in combination with other medications. When you start Victoza, your healthcare provider may decrease some of your other diabetes medications in order to avoid low blood glucose levels, but this is very individual and based upon your blood glucose levels prior to starting the medication. Victoza may or may not be covered under Medicare Part Ddepending on what plan you have. If you have a prescription for Victoza, the pharmacist can submit it to see if it will be covered. You may also want to call your Medicare Part D insurer and ask if Victoza is covered, and if not, what you might be able to do to get coverage.

2 replies

TheWingnut 2012-03-14 14:39:57 -0500 Report

Victoza was working great for me I had lost weight and finding the need for less and less insulin. Then at the first of this year the price or the part my insurance would cover changed greatly. Victoza now costs me $275.00 a month after insurance payment of $275.00. $550.00 for a month's supply ;( Needless to say I have had to suspend my use of Victoza…

Dr. William Sullivan
Dr. William Sullivan 2012-03-14 11:45:08 -0500 Report

Victoza is a medication in the class of GLP-1 agonists. The other medications in this class include Byetta and recently approved Bydureon. These medications can improve diabetes control as well as promote weight loss. Byetta is a twice-a-day injectable medication taken within 60 minutes of a meal, whereas Victoza is a once-a-day injection. Bydureon is a long-acting form of Byetta taken once weekly. The possible side effects of these medications are similar and include nausea, vomiting, diarrhea and headache. There is evidence that Victoza may cause a certain type of thyroid cancer called medullary thyroid cancer in rodents, but this has not been demonstrated in human studies. However, if there is a family history of medullary carcinoma of the thyroid, Victoza is contraindicated. Also, there has been some question whether Victoza might be associated with an increased risk of pancreatitis (inflammation of the pancreas). This possibility is being looked at further by the FDA, but a clear association has not been established.